Cover Image

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

Abstract Background Alcohol consumption is a known risk factor for liver disease in HIV-infected populations. Therefore, knowledge of alcohol consumption behaviour and risk of disease progression associated with hazardous drinking are important in the overall management of HIV disease. We aimed at a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Milensu Shanyinde (Author), Enrico Girardi (Author), Massimo Puoti (Author), Andrea De Luca (Author), Laura Sighinolfi (Author), Uberti Foppa Caterina (Author), Pietro Caramello (Author), Fiona C. Lampe (Author), Antonella D'Arminio Monforte (Author), Alessandro Cozzi-Lepri (Author), for the ICONA Foundation Study Group (Author)
Format:	Book
Published:	BMC, 2019-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy
by: Annalisa Saracino, et al.
Published: (2018)

Determinants of access to experimental antiretroviral drugs in an Italian cohort of patients with HIV: a multilevel analysis
by: Girardi Enrico, et al.
Published: (2012)

Unawareness of HCV serostatus among persons newly diagnosed with HIV
by: Paola Scognamiglio, et al.
Published: (2019)

Virological impact of HCV elimination with DAAs in the HIV reservoir in HIV/HCV patients
by: M. Coiras, et al.
Published: (2019)

Ability to Monitor National Responses to the HIV Epidemic "Beyond Viral Suppression": Findings From Six European Countries
by: Kelly Safreed-Harmon, et al.
Published: (2020)

Multidisciplinary approach for the treatment of 1155 HCV/HCV-HIV co-infected patients
by: Isabelle Ravaux, et al.
Published: (2016)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
by: Anna Turkova, et al.
Published: (2015)

Hepatitis C (HCV) therapy for HCV mono-infected and HIV-HCV co-infected individuals living in Nepal.
by: Sudhamshu Kc, et al.
Published: (2020)

Differences in the proviral HIV DNA between HIV monoinfected and HIV/HCV coinfected individuals
by: M.S. Carrillo, et al.
Published: (2017)

Identifying smoking cessation targets for people living with HIV and HIV-HCV
by: Blake Linthewaite, et al.
Published: (2018)

Effect of HCV on lipids profile of HIV patients
by: Mehrnaz Rasoolinejad, et al.
Published: (2011)

The involvement of microRNAs in HCV and HIV infection
by: Nicky Joshi, et al.
Published: (2022)

Virological Mechanisms in the Coinfection between HIV and HCV
by: Maria Carla Liberto, et al.
Published: (2015)

Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study
by: Antinori A, et al.
Published: (2016)

Co-infecção por HIV/HCV em hospital universitário de Recife, Brasil Coinfección por HIV/HCV en hospital universitario de Recife, Brasil HIV/HCV coinfection at an university hospital in Recife, Brazil
by: Flávia Helena Pontes de Carvalho, et al.
Published: (2009)

Heme and HO-1 inhibition of HCV, HBV, and HIV
by: Warren N Schmidt, et al.
Published: (2012)

The role of community pharmacies in the HIV and HCV care continuum
by: Sorosh Kherghehpoush, et al.
Published: (2023)

A Quantitative Estimate of the Expected Shortening of the Median Isolation Period of Patients With COVID-19 After the Adoption of a Symptom-Based Strategy
by: Francesca Bai, et al.
Published: (2021)

Monkeypox epidemic in prisons: How to prevent it?
by: N. Cocco, et al.
Published: (2022)

Co-infecção HIV/HCV em pacientes de Botucatu e região HIV/HCV co-infection in patients from Botucatu and region (Brazilian cities)
by: Sílvia M. Corvino, et al.
Published: (2007)

Intrauterine Blood Transfusion in an HCV and HIV Co-Infected Woman
by: Jodie C. Charison, et al.
Published: (2021)

Efficacy of Sovodak in the Management of Patients Co-infected with HIV/HCV
by: Mohammad Hossein Somi, et al.
Published: (2020)

Carpal tunnel syndrome in HIV-positive patients coinfected with HCV
by: A. Mastroianni, et al.
Published: (2017)

Continued high prevalence of HIV, HBV and HCV among injecting and noninjecting drug users in Italy
by: Laura Camoni, et al.
Published: (2010)

Sustained Long-Term Decline in Anti-HCV Neutralizing Antibodies in HIV/HCV-Coinfected Patients Five Years after HCV Therapy: A Retrospective Study
by: Daniel Sepúlveda-Crespo, et al.
Published: (2024)

Equitable access to HCV care in HIV-HCV co-infection can be achieved despite barriers to health care provision
by: Curtis L Cooper, et al.
Published: (2010)

HCV co-infection in HIV positive population in British Columbia, Canada
by: Spinelli John J, et al.
Published: (2010)

Prevalence and features of the course of HIV/HCV co-infection in pregnant women
by: A. A. Khamatova, et al.
Published: (2023)

Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana
by: Arora Dimple, et al.
Published: (2010)

Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
by: Rubén Martín-Escolano, et al.
Published: (2024)

Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection
by: Olea Jr A, et al.
Published: (2018)

Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison Correlação entre HIV e HCV em prisioneiros brasileiros: evidência de transmissão parenteral no encarceramento
by: MN Burattini, et al.
Published: (2000)

O5 Hepatitis C elimination in HIV/HCV co-infection through HCV treatment in primary care is feasible and highly effective
by: J.S. Doyle, et al.
Published: (2017)

O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy
by: Marianne Martinello, et al.
Published: (2017)

Postexposition prophylaxis for hepatotropic viruses (HBV and HCV) and human immunodeficiency virus (HIV)
by: Latković Marina B.
Published: (2010)

Prospective HIV, HBV, HCV screening in a cancer center emergency department
by: Bruno Granwehr, et al.
Published: (2016)

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
by: Germana Henry Leyna, et al.
Published: (2019)

Management Of Occupational Exposure To Bloodborne Pathogens - Hiv, Hbv, Hcv, In Maputo Public Hospitals
by: Olegario Muanantatha
Published: (2022)

SIGNIFICANCE OF IMMUNOSUPPRESSION AND ELASTOMETRY INDICES OF LIVER IN THE TACTICS OF HIV/HCV CO-INFECTION TREATMENT
by: E.R. RAKHMANOV, et al.
Published: (2017)

Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison
by: Burattini MN, et al.
Published: (2000)